| Serial Number | 88188981 |
| Word Mark | ELEV8BIO |
| Filing Date | Saturday, November 10, 2018 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, September 12, 2019 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research services in the field of cancer; Pharmaceutical research and development; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research and development; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of Cancer and Acute and Chronic Devastating Diseases and Conditions beyond Cancer; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Investor development and management; Business development, marketing strategy development and implementation; Advisory board development and management; Regulatory compliance development and management |
| Pseudo Mark | ELEVATE BIO |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 28, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, September 1, 2017 |
| First Use In Commerce Date | Friday, September 1, 2017 |
| Party Name | Elev8Bio LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Seattle, WA 98115 |
| Event Date | Event Description |
| Thursday, September 12, 2019 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, September 12, 2019 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, February 14, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, February 14, 2019 | NON-FINAL ACTION E-MAILED |
| Thursday, February 14, 2019 | NON-FINAL ACTION WRITTEN |
| Thursday, February 14, 2019 | ASSIGNED TO EXAMINER |
| Wednesday, January 30, 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, November 28, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Wednesday, November 14, 2018 | NEW APPLICATION ENTERED IN TRAM |